GKOS  valuation analysis

Name: Glaukos Corporation
Description: Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. (more)
Industry: Medical Devices
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 04, 2022
Market cap: $1.97B (1026th)
Sales(TTM): $293.72M (1321st)
Earnings(TTM): -$27.75M (1291st)

FFER: 3.31*
Actual price: $39.83
* Earnings were reported Aug 03, 2022 but we do not have the financials for this quarter. This is likely because the company has not yet released them. However, it might also be a problem with data quality. Regardless, you should take the FFER above with a grain of salt until we get updated financials.

Prices as of EOD 2022-05-25
Price & Estimates
Sales & Earnings history (TTM)
No notables found through heuristics.
Earnings / MarketCap
Glaukos Corporation
"Medical Devices" industry
Sales / MarketCap
Glaukos Corporation
"Medical Devices" industry
Book / MarketCap
Glaukos Corporation
"Medical Devices" industry
Equity / Assets
Glaukos Corporation
"Medical Devices" industry